Last Updated: August 12, 2026

CLINICAL TRIALS PROFILE FOR TIVDAK

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for TIVDAK

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03245736 ↗	Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.	Completed	Genmab	Phase 2	2017-08-23	The purpose of the trial is to evaluate efficacy and safety of continued treatment with tisotumab vedotin.
NCT03245736 ↗	Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.	Completed	Seagen Inc.	Phase 2	2017-08-23	The purpose of the trial is to evaluate efficacy and safety of continued treatment with tisotumab vedotin.
NCT03438396 ↗	A Trial of Tisotumab Vedotin in Cervical Cancer	Active, not recruiting	Belgian Gynaecological Oncology Group	Phase 2	2018-06-12	A Single arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer.
NCT03438396 ↗	A Trial of Tisotumab Vedotin in Cervical Cancer	Active, not recruiting	European Network of Gynaecological Oncological Trial Groups (ENGOT)	Phase 2	2018-06-12	A Single arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer.
NCT03438396 ↗	A Trial of Tisotumab Vedotin in Cervical Cancer	Active, not recruiting	Genmab	Phase 2	2018-06-12	A Single arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for TIVDAK

Condition Name

Chart
Table

Condition Name for TIVDAK
Intervention	Trials
Cervical Cancer	2
Endometrium Cancer	1
Esophagus Cancer	1
Lung Cancer, Nonsmall Cell	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for TIVDAK
Intervention	Trials
Uterine Cervical Neoplasms	3
Genital Diseases, Female	1
Head and Neck Neoplasms	1
Female Urogenital Diseases and Pregnancy Complications	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for TIVDAK

Trials by Country

Map
Table

Trials by Country for TIVDAK
Location	Trials
United States	25
Belgium	1
Germany	1
Sweden	1
Denmark	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for TIVDAK
Location	Trials
Florida	3
Oklahoma	2
Ohio	2
Nevada	2
Virginia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for TIVDAK

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for TIVDAK
Clinical Trial Phase	Trials
PHASE4	1
Phase 2	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for TIVDAK
Clinical Trial Phase	Trials
RECRUITING	1
Active, not recruiting	1
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TIVDAK

Sponsor Name

Chart
Table

Sponsor Name for TIVDAK
Sponsor	Trials
Genmab	5
Seagen Inc.	2
European Network of Gynaecological Oncological Trial Groups (ENGOT)	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for TIVDAK
Sponsor	Trials
Industry	9
Other	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.